Suppr超能文献

葡萄糖耐量异常患者睡眠与胰高血糖素样肽1之间的关系。

The relationship between sleep and glucagon-like peptide 1 in patients with abnormal glucose tolerance.

作者信息

Reutrakul Sirimon, Sumritsopak Rungtip, Saetung Sunee, Chanprasertyothin Suwannee, Anothaisintawee Thunyarat

机构信息

Division of Endocrinology and Metabolism, Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.

Research Center, Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.

出版信息

J Sleep Res. 2017 Dec;26(6):756-763. doi: 10.1111/jsr.12552. Epub 2017 May 31.

Abstract

Glucagon-like peptide 1 plays a role in glucose regulation. Sleep disturbances (obstructive sleep apnea, insufficient or poor sleep quality) have been shown to adversely affect glucose metabolism. This study aimed to explore the relationship between sleep and glucagon-like peptide 1 regulation in patients with abnormal glucose tolerance. Seventy-one adults with haemoglobin A1c levels between 5.7% and < 6.5% and no history of diabetes participated. Habitual sleep duration and efficiency were obtained from 7-day actigraphy recordings. Obstructive sleep apnea was assessed using an overnight home monitor. Glucagon-like peptide 1 levels were measured during a 75-g glucose tolerance. The area under the curve of glucagon-like peptide 1 was calculated. The mean age (SD) was 55.1 (8.3) years and median (interquartile range) haemoglobin A1c was 5.97% (5.86, 6.23). There was no relationship between sleep duration or efficiency and fasting or area under the curve glucagon-like peptide 1. Glucagon-like peptide 1 levels did not differ among those sleeping ≤ 5.75, > 5.75-< 6.5 or ≥ 6.5 h per night. Increasing apnea-hypopnea index, an indicator of obstructive sleep apnea severity, correlated with lower area under the curve glucagon-like peptide 1 (B -0.242, P = 0.045), but not with fasting glucagon-like peptide 1 (B -0.213, P = 0.079). After adjusting for sex, haemoglobin A1c and body mass index, increasing apnea-hypopnea index was negatively associated with having area under the curve glucagon-like peptide 1 in the highest quartile (odds ratio 0.581, P = 0.028, 95% CI 0.359, 0.942). This study demonstrated that increasing obstructive sleep apnea severity was associated with lower glucagon-like peptide 1 response to glucose challenge. This could possibly be an additional mechanism by which obstructive sleep apnea affects glucose metabolism. Whether raising glucagon-like peptide 1 levels in patients with abnormal glucose tolerance with more severe obstructive sleep apnea will be beneficial should be explored.

摘要

胰高血糖素样肽1在血糖调节中发挥作用。睡眠障碍(阻塞性睡眠呼吸暂停、睡眠不足或睡眠质量差)已被证明会对糖代谢产生不利影响。本研究旨在探讨糖耐量异常患者睡眠与胰高血糖素样肽1调节之间的关系。71名血红蛋白A1c水平在5.7%至<6.5%之间且无糖尿病史的成年人参与了研究。通过7天的活动记录仪记录获取习惯性睡眠时间和睡眠效率。使用夜间家用监测仪评估阻塞性睡眠呼吸暂停。在75克葡萄糖耐量试验期间测量胰高血糖素样肽1水平。计算胰高血糖素样肽1的曲线下面积。平均年龄(标准差)为55.1(8.3)岁,血红蛋白A1c的中位数(四分位间距)为5.97%(5.86,6.23)。睡眠时间或睡眠效率与空腹或胰高血糖素样肽1的曲线下面积之间没有关系。每晚睡眠时间≤5.75小时、>5.75至<6.5小时或≥6.5小时的人群中,胰高血糖素样肽1水平没有差异。作为阻塞性睡眠呼吸暂停严重程度指标的呼吸暂停低通气指数增加,与胰高血糖素样肽1的曲线下面积降低相关(B -0.242,P = 0.045),但与空腹胰高血糖素样肽1无关(B -0.213,P = 0.079)。在对性别、血红蛋白A1c和体重指数进行校正后,呼吸暂停低通气指数增加与胰高血糖素样肽1曲线下面积处于最高四分位数呈负相关(比值比0.581,P = 0.028,95%置信区间0.359,0.942)。本研究表明,阻塞性睡眠呼吸暂停严重程度增加与对葡萄糖挑战的胰高血糖素样肽1反应降低有关。这可能是阻塞性睡眠呼吸暂停影响糖代谢的另一种机制。对于阻塞性睡眠呼吸暂停更严重的糖耐量异常患者,提高胰高血糖素样肽1水平是否有益有待探索。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验